- GlobeNewswire•16 days ago
COLUMBIA, Md., Feb. 10, 2017-- Osiris Therapeutics, Inc. is pleased to announce that its Board of Directors, at a Board Meeting on February 7 th, 2017, confirmed the appointment of Messrs. Uwe Sommer and ...
- GlobeNewswire•last monthOsiris Therapeutics announced a Comparative Effectiveness Study on the Use of Two Human Placental Membranes in Wound Management is Available Electronically in a Peer-Reviewed Journal
COLUMBIA, Md., Jan. 19, 2017-- Osiris Therapeutics, Inc. announced today that the study“ A Comparative Outcomes Analysis Evaluating Clinical Effectiveness in Two Different Human Placental Membrane Products ...
- GlobeNewswire•last monthOsiris Therapeutics Announces Scientific Manuscript Reporting Antimicrobial Properties of Cryopreserved Viable Amnion is Available Electronically in Peer-Reviewed Journal
COLUMBIA, Md., Jan. 13, 2017-- Osiris Therapeutics, Inc., announced today that a new peer-reviewed manuscript“ Human cryopreserved viable amniotic membrane inhibits the growth of bacteria associated with ...
OSIR : Summary for Osiris Therapeutics, Inc. - Yahoo Finance
Osiris Therapeutics, Inc. (OSIR)
NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
|Day's Range||5.58 - 5.74|
|52 Week Range||3.55 - 7.87|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||134.76|
|Dividend & Yield||0.00 (0.00%)|
|1y Target Est||N/A|